EU-Australia Free Trade Agreement

EU-Australia trade agreement could mean higher medicine prices say experts

25 September 2018: A recent article in The Conversation by public health experts confirms that the EU is seeking stronger monopolies  on medicines, including the most expensive biologic medicines  used to treat cancer and other life-threatening diseases.  This would delay the availability of cheaper versions of those medicines. If Australia agrees, these provisions would have the likely effect of extending the period for which Australia subsidises already very expensive medicines.

European Court decision that ISDS is incompatible with national legal autonomy undermines ISDS in the TPP-11

April 3, 2018: The European Court of Justice ruled in March that Investor-State Dispute Settlement (ISDS) between two EU member states, which allows corporations to sue governments for damages over changes in domestic law, has an adverse effect on the autonomy of EU law, and is therefore incompatible with EU law.

European Court says States should decide on ISDS

On 16 May 2017, the Court of Justice of the European Union (CJEU) issued the long-awaited landmark Opinion 2/15 on the EU-Singapore Free Trade Agreement (FTA). According to the CJEU, the agreement falls under the EU’s powers, but not entirely. EU Member States’ national and regional parliaments and the European Parliament must ratify some important provisions regarding investors, particularly ISDS.

Pages